ZA971715B - Method of reducing tissue damage associated with ischemia - Google Patents
Method of reducing tissue damage associated with ischemiaInfo
- Publication number
- ZA971715B ZA971715B ZA971715A ZA971715A ZA971715B ZA 971715 B ZA971715 B ZA 971715B ZA 971715 A ZA971715 A ZA 971715A ZA 971715 A ZA971715 A ZA 971715A ZA 971715 B ZA971715 B ZA 971715B
- Authority
- ZA
- South Africa
- Prior art keywords
- ischemia
- tissue damage
- reducing tissue
- damage associated
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1270896P | 1996-02-29 | 1996-02-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA971715B true ZA971715B (en) | 1998-08-27 |
Family
ID=21756305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA971715A ZA971715B (en) | 1996-02-29 | 1997-02-27 | Method of reducing tissue damage associated with ischemia |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5932581A (pt) |
| EP (1) | EP0791355B1 (pt) |
| JP (1) | JPH09316004A (pt) |
| KR (1) | KR100219972B1 (pt) |
| CN (1) | CN1165000A (pt) |
| AT (1) | ATE216226T1 (pt) |
| AU (1) | AU714038B2 (pt) |
| CA (1) | CA2198536C (pt) |
| DE (1) | DE69711965T2 (pt) |
| DK (1) | DK0791355T3 (pt) |
| ES (1) | ES2174176T3 (pt) |
| IL (1) | IL120271A (pt) |
| MY (1) | MY118982A (pt) |
| PT (1) | PT791355E (pt) |
| ZA (1) | ZA971715B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL350884A1 (en) * | 1999-04-01 | 2003-02-10 | Pfizer Prod Inc | Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| CN104346404B (zh) * | 2013-08-08 | 2018-05-18 | 华为技术有限公司 | 一种访问数据的方法、设备及系统 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3905364A1 (de) | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| DE4025387A1 (de) | 1990-08-10 | 1992-02-13 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
| US5728704A (en) | 1992-09-28 | 1998-03-17 | Pfizer Inc. | Substituted pyridmidines for control of diabetic complications |
-
1997
- 1997-02-13 PT PT97200415T patent/PT791355E/pt unknown
- 1997-02-13 EP EP97200415A patent/EP0791355B1/en not_active Expired - Lifetime
- 1997-02-13 DE DE69711965T patent/DE69711965T2/de not_active Expired - Fee Related
- 1997-02-13 AT AT97200415T patent/ATE216226T1/de not_active IP Right Cessation
- 1997-02-13 DK DK97200415T patent/DK0791355T3/da active
- 1997-02-13 ES ES97200415T patent/ES2174176T3/es not_active Expired - Lifetime
- 1997-02-20 IL IL12027197A patent/IL120271A/en not_active IP Right Cessation
- 1997-02-20 US US08/803,302 patent/US5932581A/en not_active Expired - Fee Related
- 1997-02-25 JP JP9040466A patent/JPH09316004A/ja active Pending
- 1997-02-26 CA CA002198536A patent/CA2198536C/en not_active Expired - Fee Related
- 1997-02-27 MY MYPI97000795A patent/MY118982A/en unknown
- 1997-02-27 ZA ZA971715A patent/ZA971715B/xx unknown
- 1997-02-27 KR KR1019970006295A patent/KR100219972B1/ko not_active Expired - Fee Related
- 1997-02-28 AU AU15009/97A patent/AU714038B2/en not_active Ceased
- 1997-02-28 CN CN97103411A patent/CN1165000A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL120271A (en) | 2001-06-14 |
| US5932581A (en) | 1999-08-03 |
| JPH09316004A (ja) | 1997-12-09 |
| AU1500997A (en) | 1997-09-04 |
| PT791355E (pt) | 2002-08-30 |
| EP0791355B1 (en) | 2002-04-17 |
| AU714038B2 (en) | 1999-12-16 |
| CA2198536C (en) | 2000-06-20 |
| ES2174176T3 (es) | 2002-11-01 |
| ATE216226T1 (de) | 2002-05-15 |
| MX9701527A (es) | 1998-06-30 |
| DE69711965D1 (de) | 2002-05-23 |
| DE69711965T2 (de) | 2003-01-23 |
| KR100219972B1 (ko) | 1999-09-01 |
| IL120271A0 (en) | 1997-06-10 |
| MY118982A (en) | 2005-02-28 |
| KR970061257A (ko) | 1997-09-12 |
| CA2198536A1 (en) | 1997-08-29 |
| DK0791355T3 (da) | 2002-06-17 |
| CN1165000A (zh) | 1997-11-19 |
| EP0791355A1 (en) | 1997-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL120264A0 (en) | Method of reducing tissue damage associated with non-cardiac ischemia | |
| AU696806B2 (en) | Soft tissue | |
| AU3008092A (en) | Novel use of modafinil | |
| ZA941890B (en) | Method for making soft tissue. | |
| NO308854B1 (no) | Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav | |
| US5269290B1 (en) | Plantar fasciotomy surgical procedure | |
| AU3397089A (en) | Hard tissue surface treatment | |
| IL114837A0 (en) | A handpiece for a device for performing laser surgery of the nose | |
| AU1939195A (en) | Corneal template for radial-keratotomy procedure | |
| EP0793441A4 (en) | TONOMETER TO BE OPERATED BY THE PATIENT | |
| ZA971715B (en) | Method of reducing tissue damage associated with ischemia | |
| AU663832B2 (en) | Easy chess-like game | |
| AU4228593A (en) | Low level laser for soft tissue treatment | |
| HU9502623D0 (en) | Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| AU7719491A (en) | Therapeutic compound | |
| EP0260790A3 (en) | Use of pinacidil in the treatment of incontinence | |
| IL132504A0 (en) | Methods for reducing fibrinogen | |
| EP0721781A3 (en) | Reduction of adipose tissue by using collagenase | |
| HU9301232D0 (en) | Sanitary pad with medical effect | |
| AU656930B2 (en) | Active oxygen inhibitor | |
| AU656930C (en) | Active oxygen inhibitor | |
| GB9319848D0 (en) | Tissue repair | |
| ZA947352B (en) | Therapeutic benzimidazoles | |
| TW352510U (en) | Panties used for old person or patient |